MTOR and diabetic kidney disease: The downregulated expression of lncRNA nuclear-enriched abundant transcript 1 (NEAT1) reduces proliferation and fibrosis in DKD via activating the Akt/mTOR signaling pathway, which may represent a novel pathological mechanism of DKD progression [42].